Reo Maruyama

8.3k total citations · 1 hit paper
98 papers, 5.1k citations indexed

About

Reo Maruyama is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Reo Maruyama has authored 98 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Molecular Biology, 34 papers in Cancer Research and 18 papers in Oncology. Recurrent topics in Reo Maruyama's work include Epigenetics and DNA Methylation (37 papers), RNA modifications and cancer (23 papers) and Cancer-related molecular mechanisms research (18 papers). Reo Maruyama is often cited by papers focused on Epigenetics and DNA Methylation (37 papers), RNA modifications and cancer (23 papers) and Cancer-related molecular mechanisms research (18 papers). Reo Maruyama collaborates with scholars based in Japan, United States and Germany. Reo Maruyama's co-authors include Hiromu Suzuki, Takashi Tokino, Eiichiro Yamamoto, Minoru Toyota, Yasuhisa Shinomura, Kohzoh Imai, Yasushi Sasaki, Masahiro Kai, Masanori Nojima and Tamotsu Sugai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Reo Maruyama

97 papers receiving 5.1k citations

Hit Papers

Fusobacterium in Colonic Flora and Molecular Features of ... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reo Maruyama Japan 40 4.0k 1.9k 1.1k 541 521 98 5.1k
Atsushi Kaneda Japan 38 3.1k 0.8× 986 0.5× 1.2k 1.1× 542 1.0× 745 1.4× 129 4.8k
Federica Gemignani Italy 37 2.3k 0.6× 1.2k 0.6× 969 0.9× 523 1.0× 290 0.6× 111 4.1k
Takeshi Nagasaka Japan 39 3.4k 0.9× 2.6k 1.4× 1.9k 1.7× 578 1.1× 598 1.1× 144 5.9k
Eiichiro Yamamoto Japan 29 2.0k 0.5× 1.0k 0.5× 686 0.6× 481 0.9× 413 0.8× 76 2.8k
Naoya Sakamoto Japan 32 1.8k 0.5× 1.0k 0.5× 1.1k 1.0× 624 1.2× 433 0.8× 172 3.2k
Cristina Peña Spain 37 3.5k 0.9× 2.1k 1.1× 1.9k 1.8× 479 0.9× 289 0.6× 73 5.4k
J.M. Jurado Spain 33 2.3k 0.6× 1.4k 0.7× 893 0.8× 308 0.6× 234 0.4× 72 3.4k
Anamaria A. Camargo Brazil 30 2.4k 0.6× 759 0.4× 906 0.8× 501 0.9× 270 0.5× 128 3.8k
Su Young Kim South Korea 33 2.7k 0.7× 660 0.4× 1.1k 1.0× 503 0.9× 268 0.5× 96 3.7k

Countries citing papers authored by Reo Maruyama

Since Specialization
Citations

This map shows the geographic impact of Reo Maruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reo Maruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reo Maruyama more than expected).

Fields of papers citing papers by Reo Maruyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reo Maruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reo Maruyama. The network helps show where Reo Maruyama may publish in the future.

Co-authorship network of co-authors of Reo Maruyama

This figure shows the co-authorship network connecting the top 25 collaborators of Reo Maruyama. A scholar is included among the top collaborators of Reo Maruyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reo Maruyama. Reo Maruyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ishiguro, Kazuya, Hiroshi Kitajima, Takeshi Niinuma, et al.. (2025). DOT1L inhibition reprograms innate immunity to potentiate immunomodulatory drug responses in multiple myeloma. Cancer Letters. 631. 217941–217941. 1 indexed citations
2.
Wang, Xingxing, Keiko Shinjo, Reo Maruyama, et al.. (2025). Transgelin defines pro-tumorigenic cancer-associated fibroblasts in pancreatic cancer. British Journal of Cancer. 134(4). 577–588.
3.
Okonechnikov, Konstantin, Stefan M. Pfister, Weijun Feng, et al.. (2025). Chromatin modification abnormalities by CHD7 and KMT2C loss promote medulloblastoma progression. Cell Reports. 44(5). 115673–115673. 1 indexed citations
4.
Murayama, Takahiko, Jun Nakayama, Kenichi Miyata, et al.. (2024). Targeting DHX9 Triggers Tumor-Intrinsic Interferon Response and Replication Stress in Small Cell Lung Cancer. Cancer Discovery. 14(3). 468–491. 47 indexed citations
5.
Takahashi, Yōko, Tomo Osako, Takayuki Kobayashi, et al.. (2024). Serial single-cell RNA sequencing unveils drug resistance and metastatic traits in stage IV breast cancer. npj Precision Oncology. 8(1). 222–222. 3 indexed citations
6.
Nakadai, Tomoyoshi, Miho Shimada, Keiichi Ito, et al.. (2023). Two target gene activation pathways for orphan ERR nuclear receptors. Cell Research. 33(2). 165–183. 14 indexed citations
7.
Yang, Liying, et al.. (2023). FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer–gene programs in basal-like breast cancer. Frontiers in Oncology. 13. 1156111–1156111. 6 indexed citations
8.
Wu, Wenwen, Nana Rokutanda, Yongqiang Lai, et al.. (2018). HERC2 Facilitates BLM and WRN Helicase Complex Interaction with RPA to Suppress G-Quadruplex DNA. Cancer Research. 78(22). 6371–6385. 47 indexed citations
9.
Tahara, Tomomitsu, Eiichiro Yamamoto, Hiromu Suzuki, et al.. (2014). Fusobacterium in Colonic Flora and Molecular Features of Colorectal Carcinoma. Cancer Research. 74(5). 1311–1318. 354 indexed citations breakdown →
10.
Suzuki, Hiromu, Eiichiro Yamamoto, Reo Maruyama, Takeshi Niinuma, & Masahiro Kai. (2014). Biological significance of the CpG island methylator phenotype. Biochemical and Biophysical Research Communications. 455(1-2). 35–42. 75 indexed citations
11.
Suzuki, Ryo, Eiichiro Yamamoto, Masanori Nojima, et al.. (2013). Aberrant methylation of microRNA-34b/c is a predictive marker of metachronous gastric cancer risk. Journal of Gastroenterology. 49(7). 1135–1144. 46 indexed citations
12.
Takamaru, Hiroyuki, Eiichiro Yamamoto, Hiromu Suzuki, et al.. (2012). Aberrant Methylation of RASGRF1 Is Associated with an Epigenetic Field Defect and Increased Risk of Gastric Cancer. Cancer Prevention Research. 5(10). 1203–1212. 32 indexed citations
13.
Sasaki, Yasushi, Ryota Koyama, Reo Maruyama, et al.. (2012). CLCA2, a target of the p53 family, negatively regulates cancer cell migration and invasion. Cancer Biology & Therapy. 13(14). 1512–1521. 51 indexed citations
14.
Sasaki, Yasushi, H. Negishi, Masashi Idogawa, et al.. (2011). p53 Negatively Regulates the Hepatoma Growth Factor HDGF. Cancer Research. 71(22). 7038–7047. 26 indexed citations
15.
Suzuki, Hiromu, Hirofumi Akashi, Eiichiro Yamamoto, et al.. (2011). Genome-wide Profiling of Chromatin Signatures Reveals Epigenetic Regulation of MicroRNA Genes in Colorectal Cancer. Cancer Research. 71(17). 5646–5658. 135 indexed citations
16.
Nojima, Masanori, Reo Maruyama, Hiroshi Yasui, et al.. (2009). Genomic Screening for Genes Silenced by DNA Methylation Revealed an Association between RASD1 Inactivation and Dexamethasone Resistance in Multiple Myeloma. Clinical Cancer Research. 15(13). 4356–4364. 53 indexed citations
17.
Toyota, Minoru, Hiromu Suzuki, Yasushi Sasaki, et al.. (2008). Epigenetic Silencing of MicroRNA-34b/c and B-Cell Translocation Gene 4 Is Associated with CpG Island Methylation in Colorectal Cancer. Cancer Research. 68(11). 4123–4132. 497 indexed citations
18.
Nishikawa, Noriko, Minoru Toyota, Hiromu Suzuki, et al.. (2007). Gene Amplification and Overexpression of PRDM14 in Breast Cancers. Cancer Research. 67(20). 9649–9657. 90 indexed citations
19.
Maruyama, Reo, Fumio Aoki, Minoru Toyota, et al.. (2006). Comparative Genome Analysis Identifies the Vitamin D Receptor Gene as a Direct Target of p53-Mediated Transcriptional Activation. Cancer Research. 66(9). 4574–4583. 86 indexed citations
20.
Maruyama, Reo, Minoru Toyota, Hiromu Suzuki, et al.. (2006). The functional relation of vitamin D receptor and p53 in cancer cells.. Cancer Epidemiology and Prevention Biomarkers. 15. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026